Family Medicine

Since many patients with night eating syndrome (NES) believe they will not fall back asleep until they ingest a full meal, it's no surprise that NES is associated with obesity and metabolic abnormalities.

Researchers analyzed records from more than 25,000 Medicare beneficiaries and found no evidence that testosterone replacement therapy increases the risk of heart attack among older men.

Human embryonic stem cells are a potentially viable treatment option for multiple sclerosis.

Study results show that treatment with etanercept is effective and well tolerated in adolescent patients with psoriatic arthritis and other rheumatic conditions.

Left untreated or inadequately treated, syphilis may cause tertiary cardiovascular disease, one form of which is syphilitic aortitis.

As research continues to be done to find the most efficient treatment for patients with plaque psoriasis a study was recently published looking at how the inclusion of topical corticosteroids can benefit the care provided.

A team of researchers has discovered a novel neurotransmission that influences addiction-related memory.

For more than 70 years methotrexate has been a popular tool in the prescription toolkit of doctors around the world. However, a recent case report by a team from the United Kingdom showed how important it is for prescribing doctors to also keep a close eye on some of the well-known adverse events associated with the medication.

For those who fail to quit smoking with varenicline treatment alone, adding a nicotine patch will likely increase the odds of tobacco abstinence at 6 months.

An endocrinologist from the University Hospital Basel in Switzerland discusses the role of inflammation in the pathogenesis of type 2 diabetes, outlining the reasons why clinicians should target inflammation when treating diabetics.

Using factors such as genetics and brain function, it is possible to predict with 70% which teenagers will become binge drinkers, according to a new study in Nature.

A pair of randomized controlled studies have both found that continuous monitoring of patients after cryptogenic strokes can detect several times as many cases of atrial fibrillation as conventional monitoring.

Analysis of emergency department cases indicates that anaphylaxis severity increases with age and other health problems, but preparations can reduce the danger to patients.

Japanese regulators have approved an all-oral daclatsvir plus asunaprevir drug regimen developed by Bristol-Meyers Squibb to treat patients with genotype 1 chronic hepatitis C.

In this particular age of the Internet and social media, losing a lawsuit is not the only thing that can damage a physician's career.

The US Food and Drug Administration recently announced it will require the makers of testosterone replacement therapies to add general warnings about venous blood clots to product labels.

Supporting a previous study that associated air pollution with autism, researchers at the University of Rochester Medical Center (URMC) have discovered an additional link between early exposure to air pollution and schizophrenia.

Among highly nicotine-dependent male smokers, therapies that combine smoking cessation agents significantly increase the likelihood of quitting, according to a study published in The American Journal of Psychiatry.

Although hospitals routinely implement peer review processes to ensure that physicians are meeting the prevailing standards of care, the procedure has been associated with controversy.

Study results show that obese patients with psoriatic arthritis who were treated with tumor necrosis factor-alpha blockers who also lost at least 5 percent of their bodyweight from baseline were much more likely to achieve minimal disease activity.

Phase II trial data suggest that a fixed-dose combination of ranolazine and low-dose dronedarone may significantly reduce disease burden among patients with atrial fibrillation.

Biologic agent golimumab effective over 5-year span in treating disease symptoms and improving quality of life.

Researchers at Wake Forest Baptist Medical Center have released a study showing the potential of a dangerous interaction between a common supplement and prescription medication.

The Food and Drug Administration (FDA) has announced the approval of a new medication aimed at helping the nearly 26 million people in the country with diabetes.

A taskforce from the European Academy of Allergy and Clinical Immunology has reviewed all the published research and formulated a new set of comprehensive guidelines for diagnosing and treating anaphylaxis.

The newest tool in the fight against drug-resistant germs may come from underneath the feet of people in Nova Scotia.

If the results of a recent study are proven to last, then the previously held belief concerning the relationship between tuberculosis and the use of corticosteroids could be considered incomplete.

Minutes and seconds can make a difference in the amount of brain damage suffered by a stroke patient, but now scientists have shown that medication can significantly help limit the damage.

Patients with psoriasis, psoriatic arthritis, or both conditions felt their quality of life decreased if they experienced condition symptoms in more parts of their body.

Cardiovascular risk related to severity of inflammation, but not associated with disease duration